If one looks at a one-day chart of AEGR and REGN on Friday, they completely diverged in the early afternoon as news from REGN cholesterol-lowering drug came out. Apparently, in the ongoing trials, some serious side effects were noted.
Was recommended today by the cheapinvestor newsletter
ML says the drug may bring $2B in sales - 10 times revenue would be appropriate. You do the math!
I have a triple in a month!
Does anyone know what the current NAV is?